Aktiesnakken — Marts 2020
-
Det er udeliv som ikke spreder smitten så kraftigt som indeliv. Det er vist uvist hvor meget temperaturen betyder.
-
Netop Solsen. Der er også viden om at kolde slimhinder er mere modtagelig for bakerier og vira. Hvorvidt covid19 er ligeglad med dette er ikke undersøgt endnu.
-
Fed-direktører tror på solid økonomisk genrejsning efter viruskrisen https://borsen.dk/nyheder/generelt/fed-direktorer-tror-paa-solid-okonomisk-genrejsning-efter-viruskrisen1
-
BREAKING: President Trump invokes the Defense Production Act to order General Motors to make ventilators for hospitals https://trib.al/6rLBt49
-
Lundbeck announces phase IIa study results of Lu AG06466 in adults with Tourette Syndrome https://investor.lundbeck.com/news-releases/news-release-details/lundbeck-announces-phase-iia-study-results-lu-ag06466-adults
-
Søren Pind
@sorenpind
Nyt resultat fra Marseille med videnskabelig artikel: 80 behandlede COVID patienter - 1 86-årig død. 78 raske el raskere.
Citér TweetDidier Raoult
@raoult_didier
· 2 t
Nouveaux résultats de l'IHU Méditerranée Infection : 80 patients traités par une association hydroxychloroquine/azithromycine.
https://mediterranee-infection.com/wp-content/uploads/2020/03/COVID-IHU-2-1.pdf
8.30 PM · 27. mar. 2020·Twitter for iPhone -
L'infirmier Ædelsten
@Infirmier0
Svarer
@raoult_didier
Kollisionssymbol Hydroxychloroquine et Azithromycine est un traitement efficace du #Covid_19fr , Comme vous pouvez le constater, les résultats sont spectaculaires à J+6 avec une baisse très importante de la charge virale. Bravo Pr #Raoult #COVID19france #COVID19 #CoronavirusFrance #COVID19fr
Oversat fra fransk af
Kollisionssymbol Hydroxychloroquin og Azithromycin er en effektiv behandling af #Covid_19fr Som du kan se, er resultaterne -
In this report we describe our results in patients treated with hydroxychloroquine in combination with azithromycin over a period of at least three days, with three main endpoints: i) clinical outcome ii) contagiousness as assessed by PCR and culture and iii) long of stay in infectious disease (ID) unit.
-
In conclusion, we confirm the efficacy of hydroxychloroquine associated with azithromycin in the treatment of COVID-19 and its potential effectiveness in the early impairment of contagiousness. Given the urgent therapeutic need to manage this disease with effective and safe drugs and given the negligible cost of both hydroxychloroquine and azithromycin, we believe that other teams should urgently evaluate this therapeutic strategy both to avoid the spread of the disease and to treat patients
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind